ConductScience.org, home
A Phase IV Study of the Safety and Efficacy of Aripiprazole in Combination With Lamotrigine in the Long-Term Maintenance Treatment of Patients With Bipolar I Disorder With A Recent Manic or Mixed Episode
API referenceFor AI assistants

Trial · NCT00277212

Participant flow30

How many started, completed or left each group, period by period.

1 to 20 of 30

Download this page as JSON
PeriodMilestoneGroupParticipantsUnits counted
Phase 1 - Single-Blind TreatmentSTARTEDPhase 1: Single-Blind Treatment, Lamotrigine + Aripiprazole787
Phase 1 - Single-Blind TreatmentSTARTEDPhase 2 Double-Blind Treatment: Lamotrigine + Placebo0
Phase 1 - Single-Blind TreatmentSTARTEDPhase 2 Double-Blind Treatment: Lamotrigine + Aripiprazole0
Phase 1 - Single-Blind TreatmentPhase 1 Safety SamplePhase 1: Single-Blind Treatment, Lamotrigine + Aripiprazole787
Phase 1 - Single-Blind TreatmentPhase 1 Safety SamplePhase 2 Double-Blind Treatment: Lamotrigine + Placebo0
Phase 1 - Single-Blind TreatmentPhase 1 Safety SamplePhase 2 Double-Blind Treatment: Lamotrigine + Aripiprazole0
Phase 1 - Single-Blind TreatmentPhase 1 Efficacy SamplePhase 1: Single-Blind Treatment, Lamotrigine + Aripiprazole756
Phase 1 - Single-Blind TreatmentPhase 1 Efficacy SamplePhase 2 Double-Blind Treatment: Lamotrigine + Placebo0
Phase 1 - Single-Blind TreatmentPhase 1 Efficacy SamplePhase 2 Double-Blind Treatment: Lamotrigine + Aripiprazole0
Phase 1 - Single-Blind TreatmentCOMPLETEDPhase 1: Single-Blind Treatment, Lamotrigine + Aripiprazole352
Phase 1 - Single-Blind TreatmentCOMPLETEDPhase 2 Double-Blind Treatment: Lamotrigine + Placebo0
Phase 1 - Single-Blind TreatmentCOMPLETEDPhase 2 Double-Blind Treatment: Lamotrigine + Aripiprazole0
Phase 1 - Single-Blind TreatmentNOT COMPLETEDPhase 1: Single-Blind Treatment, Lamotrigine + Aripiprazole435
Phase 1 - Single-Blind TreatmentNOT COMPLETEDPhase 2 Double-Blind Treatment: Lamotrigine + Placebo0
Phase 1 - Single-Blind TreatmentNOT COMPLETEDPhase 2 Double-Blind Treatment: Lamotrigine + Aripiprazole0
Phase 2 - Double-Blind TreatmentSTARTEDPhase 1: Single-Blind Treatment, Lamotrigine + Aripiprazole0
Phase 2 - Double-Blind TreatmentSTARTEDPhase 2 Double-Blind Treatment: Lamotrigine + Placebo173
Phase 2 - Double-Blind TreatmentSTARTEDPhase 2 Double-Blind Treatment: Lamotrigine + Aripiprazole178
Phase 2 - Double-Blind TreatmentPhase 2 Safety SamplePhase 1: Single-Blind Treatment, Lamotrigine + Aripiprazole0
Phase 2 - Double-Blind TreatmentPhase 2 Safety SamplePhase 2 Double-Blind Treatment: Lamotrigine + Placebo165

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00277212/flow

API referenceFor AI assistants